The mean weight of endometriosis lesions in the groups treated with anti-VEGF/VEGFR agents was significantly less than that of the untreated animals (SMD –1.70, 95% CI –2.75 to –0.65; P = 0.002; Fig 2B). This evidence concerns the gene VEGFA and endometriosis.